The First Case of Postpartum Acquired Hemophilia A in Korea.
10.3346/jkms.2011.26.9.1247
- Author:
Ji Hyun LEE
1
;
Dong Hwan KIM
;
Kiyoung YOO
;
Yongmook CHOI
;
Sun Hee KIM
;
Hee Jin KIM
Author Information
1. Department of Laboratory Medicine & Genetics, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea. heejinkim@skku.edu
- Publication Type:Case Report ; Research Support, Non-U.S. Gov't
- Keywords:
Acquired hemophilia A;
Postpartum;
Factor VIII inhibitor;
Korea
- MeSH:
Adrenal Cortex Hormones/therapeutic use;
Adult;
Autoantibodies/blood;
Blood Coagulation Factors/therapeutic use;
Factor VIII/immunology;
Factor VIIa/therapeutic use;
Female;
Hematoma/diagnosis;
Hemophilia A/*diagnosis/therapy;
Humans;
Partial Thromboplastin Time;
Postpartum Period;
Pregnancy;
Recombinant Proteins/therapeutic use;
Republic of Korea
- From:Journal of Korean Medical Science
2011;26(9):1247-1249
- CountryRepublic of Korea
- Language:English
-
Abstract:
Acquired hemophilia A (AHA) is a rare coagulopathy caused by autoantibodies to coagulation factor VIII (FVIII). Most patients with AHA have been previously healthy; however, a variety of morbidities have been associated with the condition including pregnancy. A 40-yr-old woman visited our institution with extensive hematoma on the right hip area. Her medical history revealed no personal or familial history of bleeding diathesis. Her coagulation tests showed markedly prolonged aPTT (117 sec), markedly decreased level of FVIII activity (0.4%) and high-titer FVIII inhibitor (77 BU). Collectively, she was diagnosed as having postpartum AHA and was treated with bypassing agents and corticosteroids. Her aPTT was normalized on the 174th postpartum day and FVIII inhibitor showed negative conversion on the 224th postpartum day. This is the first case of postpartum AHA with high-titer FVIII inhibitor in Korea. Timely diagnosis and management can reduce morbidity and mortality of this potentially life-threatening condition.
